The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment: Including myocarditis and the new entity of non inflammatory left ventricular dysfunction

BACKGROUND: The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to describe the spectrum of cardiovascular adverse events (cvAEs) by presenting our real-world experience of the diagnosis and management of these compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Andres, Maria Sol, Ramalingam, Sivatharshini, Rosen, Stuart D., Baksi, John, Khattar, Rajdeep, Kirichenko, Yulia, Young, Kate, Yousaf, Nadia, Okines, Alicia, Huddart, Robert, Harrington, Kevin, Furness, Andrew J.S., Turajlic, Samra, Pickering, Lisa, Popat, Sanjay, Larkin, James, Lyon, Alexander R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685864/
https://www.ncbi.nlm.nih.gov/pubmed/36424659
http://dx.doi.org/10.1186/s40959-022-00147-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685864/
https://www.ncbi.nlm.nih.gov/pubmed/36424659
http://dx.doi.org/10.1186/s40959-022-00147-w

Ejemplares similares